glp-1 multiple endocrine neoplasia Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management GLP-1R agonist promotes proliferation of

Under normal conditions, it is produced in small quantities and has a short half-life, but its impact on appetite control and blood glucose controlis very significant

Experts also stress the need to expand access to these therapies for those most likely to benefit, noting that inadequate insurance coverage remains a major barrier for patients.[137] These benefits likely arise from a combination of mechanisms, including weight loss, improved glycemic control, reduced ectopic fat deposition, and decreased systemic inflammation, all of which contribute to enhanced vascular health

Even indirect bright light can cause damage over time

[23]Akmal M, Jianming XJ